224 related articles for article (PubMed ID: 30091709)
1. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging: A novel approach to assessing treatment in locally advanced esophageal cancer patients.
Gu L; Xie X; Guo Z; Shen W; Qian P; Jiang N; Fan Y
Niger J Clin Pract; 2021 Dec; 24(12):1800-1807. PubMed ID: 34889788
[TBL] [Abstract][Full Text] [Related]
3. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Multiparametric MRI May Augment the Response to Radiotherapy in Mid-Treatment Assessment of Patients with Esophageal Carcinoma.
Xie T; Ye Z; Pang P; Shao G
Oncol Res Treat; 2019; 42(6):326-333. PubMed ID: 31064001
[TBL] [Abstract][Full Text] [Related]
6. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
[TBL] [Abstract][Full Text] [Related]
8. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.
Zheng H; Ren W; Pan X; Zhang Q; Liu B; Liu S; He J; Zhou Z
J Magn Reson Imaging; 2018 Aug; 48(2):349-358. PubMed ID: 29297204
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
[TBL] [Abstract][Full Text] [Related]
10. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review.
Dijkhoff RAP; Beets-Tan RGH; Lambregts DMJ; Beets GL; Maas M
Eur J Radiol; 2017 Oct; 95():155-168. PubMed ID: 28987662
[TBL] [Abstract][Full Text] [Related]
11. Preliminary study of IVIM-DWI and DCE-MRI in early diagnosis of esophageal cancer.
Lei J; Tian Y; Zhu SC; Han Q; Wei Y; Yang S; Shi DP
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3345-50. PubMed ID: 26439027
[TBL] [Abstract][Full Text] [Related]
12. DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
King AD; Chow SK; Yu KH; Mo FK; Yeung DK; Yuan J; Law BK; Bhatia KS; Vlantis AC; Ahuja AT
PLoS One; 2015; 10(12):e0144770. PubMed ID: 26657972
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
14. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
16. Early assessment of response to chemotherapy in lung cancer using dynamic contrast-enhanced MRI: a proof-of-concept study.
Xu J; Mei L; Liu L; Wang K; Zhou Z; Zheng J
Clin Radiol; 2018 Jul; 73(7):625-631. PubMed ID: 29571650
[TBL] [Abstract][Full Text] [Related]
17. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of semi-quantitative and quantitative dynamic contrast-enhanced MRI in evaluating the response to concurrent chemoradiotherapy in patients with non-small cell lung cancer].
Xiuli T; Han O; Ning W; Li L; Feng Y; Ying S; Peihua W; Lü L
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):272-7. PubMed ID: 26462891
[TBL] [Abstract][Full Text] [Related]
19. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
